CN
|
EN
Home
Introduction to the 2022 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Register
Roadshow Application
Roadshow Center)
CN
EN
Investors’ Experience Sharing Forum
Schedule
Profile details
8:30 AM-10:30 AM 第一阶段 Phase I
Moderator
马超,中国医药创新促进会综合部副主任
MA Chao,Deputy Director of Administrative Office, China Pharmaceutical Innovation and Research Development Association(PhIRDA)
8:30 AM-9:00 AM 第一阶段 Phase I
主题报告1
Keynote Speech 1
创新、责任、科技:中国生物医药产业的投资趋势
Innovation, Responsibility, Technology: the Trend of Investment in China’s Biotech Industry
陆潇波,红杉资本中国基金合伙人
LU Xiaobo,Partner, Sequoia China
9:00 AM-9:30 AM
主题报告2
Keynote Speech 2
投资机构如何赋能被投企业
How PE Can Empower Portfolio
施珑,华平投资合伙人
Leo SHI, Managing Director, Warburg Pincus
9:30 AM-10:00 AM
主题报告3
Keynote Speech 3
坚定做好生物医药行业“挖井人”
Persistently Promote the Development of Biomedical Industry
朱晋桥, 倚锋资本董事长
ZHU Jinqiao, Chairman, Efung Capital
10:00 AM-10:30 AM
主题报告4
Keynote Speech 4
药品跨境交易新模式及其挑战
Cross-border Drug Deals: New Models and Challenges
朱敏, 汉坤律师事务所合伙人
ZHU Min,Partner, Han Kun Law Offices
10:30 AM-12:00 AM 第二阶段 Phase II
10:30 AM-11:15 AM
主题讨论1
Panel 1
创新药企投资价值与二级市场股票价格的差异分析
Differential Analysis Between the Investment Value of Innovative Pharmaceutical Companies and the Stock Price in Secondary Market
Moderator
胡雪峰,南京和润资本董事长、中国药促会投资专委会秘书长
HU Xuefeng,Secretary General, Investment Committee of China Pharmaceutical Innovation and Research Development Association(PhIRDA)
Panelists
张莉, 齐济投资创始合伙人
陶峰,博远资本创始合伙人
李凯军,醴泽资本管理合伙人
林亮,礼来亚洲基金合伙人
周成曜,汉坤律师事务所合伙人
Lily ZHANG, Founding Partner, TTM capital
TAO Feng, Founding Partner, BioTrack Capital
Kevin LI, LYZZ Capital Advisors Ltd & Managing Partner
Stephen LIN, Partner, Lilly Asia Ventures
Aaron ZHOU, Partner, Han Kun Law Offices
11:15 AM-12:00 AM
主题讨论2
Panel 2
医药创新数字化投资趋势展望与策略分享
Prospects and Strategy Sharing of Digital Medicine Investment Trends
Moderator
孙喆,中国医药创新促进会医药创新数字化推进办公室主任
SUN Zhe,Director, Pharmaceutical Innovation Digitalization Promotion Office(PhIRDA)
Panelists
王淮, 线性资本创始人兼首席执行官
陈刚,洲嶺资本管理合伙人
张楠,时节创投管理合伙人
严庆隆,海纳亚洲创投合伙人
陈志行,大钲资本合伙人
Harry WANG, Founder and CEO, Linear Capital
Jack CHEN, Managing Partner, LYFE Capital
ZHANG Nan, Managing Partner, Momentum Venture
Ryushi Shinagawa, Partner, Susquehanna International Group
CHEN Zhixing, Partner, Centurium Capital
Specification:
Released:
September 17, 2020
Last update:
September 19, 2020
Version:
1.1
010-58156160
Contact US